Physician profile
Christopher Coufal
NPI 1467402859
$1,371.03
in general payments reported to CMS, 2019-2025
15 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $52.68 · 2021: $180 · 2022: $134 · 2023: $120 · 2024: $127 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $239.88 | 2021-2024 | Precice Intramedullary Limb Lengthening System |
| Stryker Corporation | $238.23 | 2019-2023 | T2 Alpha, Variax |
| Nuvasive Specialized Orthopedics, INC. | $195.04 | 2019 | |
| Acera Surgical, INC. | $140.80 | 2025 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $114.37 | 2019 | |
| Sanara Medtech INC. | $97.80 | 2021-2025 | Celleraterx, Celleraterx |
| Medshape, INC. | $55.49 | 2019 | |
| Zimmer Biomet Holdings, INC. | $50.55 | 2019-2022 | |
| Si-Bone, INC. | $48.95 | 2022 | |
| Bioventus LLC | $45.67 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $44.84 | 2020-2021 | |
| Smith+Nephew, INC. | $41.62 | 2023 | Stravix |
| Molnlycke Health Care US, LLC | $20.91 | 2025 | Avance, Mepilex Border Post-Op |
| Team_makena_llc | $20.00 | 2019 | |
| Wright Medical Technology, INC. | $16.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Coufal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.